Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.

ABSTRACT:

SUBMITTER: Clamp AR 

PROVIDER: S-EPMC9630160 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature